ZA200502307B - Method for treating patients with massive blood loss - Google Patents

Method for treating patients with massive blood loss

Info

Publication number
ZA200502307B
ZA200502307B ZA2005/02307A ZA200502307A ZA200502307B ZA 200502307 B ZA200502307 B ZA 200502307B ZA 2005/02307 A ZA2005/02307 A ZA 2005/02307A ZA 200502307 A ZA200502307 A ZA 200502307A ZA 200502307 B ZA200502307 B ZA 200502307B
Authority
ZA
South Africa
Prior art keywords
blood loss
treating patients
massive blood
massive
patients
Prior art date
Application number
ZA2005/02307A
Other languages
English (en)
Inventor
Stevan A Gould
Richard E Dewoskin
Marc D Doubleday
George A Hides
Original Assignee
Northfield Laboratorie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northfield Laboratorie Inc filed Critical Northfield Laboratorie Inc
Publication of ZA200502307B publication Critical patent/ZA200502307B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA2005/02307A 2002-10-03 2005-03-18 Method for treating patients with massive blood loss ZA200502307B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41593502P 2002-10-03 2002-10-03
PCT/US2003/031377 WO2004037279A1 (en) 2002-10-03 2003-10-03 Method for treating patients with massive blood loss

Publications (1)

Publication Number Publication Date
ZA200502307B true ZA200502307B (en) 2005-11-30

Family

ID=32176456

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2005/02307A ZA200502307B (en) 2002-10-03 2005-03-18 Method for treating patients with massive blood loss

Country Status (11)

Country Link
US (1) US7291592B2 (enExample)
EP (1) EP1553968A4 (enExample)
JP (1) JP2006502231A (enExample)
CN (1) CN1703235A (enExample)
AU (1) AU2003272827B2 (enExample)
CA (1) CA2499459A1 (enExample)
MX (1) MXPA05003340A (enExample)
NO (1) NO20051390L (enExample)
RU (1) RU2325924C2 (enExample)
WO (1) WO2004037279A1 (enExample)
ZA (1) ZA200502307B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050049707A1 (en) * 2003-08-29 2005-03-03 Ferree Bret A. Cemented artificial disc replacements
US7747315B2 (en) * 2002-01-15 2010-06-29 Board Of Regents, The University Of Texas System Methods and compositions to reduce scattering of light during therapeutic and diagnostic imaging procedures
US20090004159A1 (en) * 2006-01-24 2009-01-01 The Board Of Trustees Of The University Of Illinoi Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells
EP1978802A2 (en) * 2006-01-24 2008-10-15 Northfield Laboratories, Inc. Polymerized hemoglobin media and its use in isolation and transplantation of islet cells
WO2008009635A2 (en) * 2006-07-17 2008-01-24 Novo Nordisk Health Care Ag Factor viia analogues with increased activity for treating thrombocytopenia
RU2361608C1 (ru) * 2008-03-18 2009-07-20 Общество С Ограниченной Ответственностью "Научно-Производственная Компания "Медбиофарм" Кровезаменитель с функцией переноса кислорода, фармацевтическая композиция (варианты)
RU2452519C1 (ru) * 2011-03-25 2012-06-10 Государственное учреждение здравоохранения Научно-исследовательский институт скорой помощи имени Н.В. Склифосовского Департамента здравоохранения г. Москвы Способ компенсации глобулярного объема крови и иммуномодулирующего воздействия при трансплантации
EP3655019A4 (en) 2017-07-18 2021-04-21 Virtech Bio, Inc. BLOOD SUBSTITUTES INCLUDING HEMOGLOBIN AND METHODS OF MANUFACTURING

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464814A (en) 1986-06-20 1995-11-07 Northfield Laboratories, Inc. Acellular red blood cell substitute
US4826811A (en) 1986-06-20 1989-05-02 Northfield Laboratories, Inc. Acellular red blood cell substitute
US5194590A (en) * 1986-06-20 1993-03-16 Northfield Laboratories, Inc. Acellular red blood cell substitute
US5854209A (en) 1995-03-23 1998-12-29 Biopure Corporation Method for oxygenating tissue having reduced red blood cell flow
US5084558A (en) 1987-10-13 1992-01-28 Biopure Corporation Extra pure semi-synthetic blood substitute
US5955581A (en) 1986-11-10 1999-09-21 Biopure Corporation Method for producing a stable polymerized hemoglobin blood-substitute
AU705225B2 (en) * 1995-03-23 1999-05-20 Biopure Corporation Stable polymerized hemoglobin blood substitute
US20020065211A1 (en) 1995-03-23 2002-05-30 Biopure Corporation Increasing function of organs having reduced red blood cell flow
US5895810A (en) 1995-03-23 1999-04-20 Biopure Corporation Stable polymerized hemoglobin and use thereof
US6150507A (en) 1995-03-23 2000-11-21 Biopure Corporation Method for producing a purified hemoglobin product
US6288027B1 (en) 1995-03-23 2001-09-11 Biopure Corporation Preserving a hemoglobin blood substitute with a transparent overwrap
US5691452A (en) 1995-03-23 1997-11-25 Biopure Corporation Method for preserving a hemoglobin blood substitute
US6271351B1 (en) 1995-03-23 2001-08-07 Biopure Corporation Method for preserving a hemoglobin blood substitute
US5691453A (en) 1995-06-07 1997-11-25 Biopure Corporation Separation of polymerized hemoglobin from unpolymerized hemoglobin on hydroxyapatite using HPLC
SK134398A3 (en) * 1996-03-28 2001-01-18 Northfield Lab Aqueous solution of the pyridoxylated polymerized hemoglobin and method for preparing the same
US5890852A (en) * 1998-03-17 1999-04-06 Emerson Electric Company Thread cutting die and method of manufacturing same

Also Published As

Publication number Publication date
AU2003272827B2 (en) 2009-03-19
NO20051390L (no) 2005-05-30
CA2499459A1 (en) 2004-05-06
US7291592B2 (en) 2007-11-06
AU2003272827A1 (en) 2004-05-13
RU2005113240A (ru) 2005-12-10
RU2325924C2 (ru) 2008-06-10
MXPA05003340A (es) 2005-07-05
WO2004037279A1 (en) 2004-05-06
US20040067876A1 (en) 2004-04-08
CN1703235A (zh) 2005-11-30
JP2006502231A (ja) 2006-01-19
EP1553968A4 (en) 2009-06-24
EP1553968A1 (en) 2005-07-20

Similar Documents

Publication Publication Date Title
EP1680166A4 (en) METHOD AND DEVICE FOR THE TREATMENT OF HEART FAILURE
GB2398810B (en) Well treatment method and system
EP1640035A4 (en) HEART TREATMENT APPARATUS AND HEART TREATMENT METHOD
IL176001A0 (en) System and method for analyzing medical treatment data
IL163704A0 (en) Method for collecting a desired blood component and performing a photopheresis treatment
AU2002325435A8 (en) Medication and method for treating pathological syndrome
AU2002349630A1 (en) Medical treatment system and production method therefor
IL175818A0 (en) Method for treating adamts-5- associated disease
AU2003277049A8 (en) Method and apparatus for hemostasis and blood management
PT1596868E (pt) Método para o tratamento de insuficiência cardíaca grave e medicamento associado
GB0129976D0 (en) Treatment method
GB0201674D0 (en) Medical treatment
ZA200409331B (en) Method of treating diabetes
GB0218879D0 (en) Medical treatment
AU2003232044A8 (en) Composition and method for dermatological treatment
GB0120147D0 (en) Treatment method
AU2003299652A8 (en) Methods for treating diabetes
GB0307544D0 (en) Treatment method
AU2003236232A1 (en) Method for treatment of textile
GB2406865B (en) Well treatment system and method
GB0126253D0 (en) Treatment method
GB0211515D0 (en) Blood treatment
AU2003271516A8 (en) Method and database for finding medical studies
GB0416872D0 (en) System and method for medical treatment
AU2002237606A1 (en) System and method for treating whole blood